US biotech firm Moderna says its COVID-19 vaccine is safe and effective in children aged six to eleven.
It comes the day before US government advisors vote on whether to authorize the Pfizer vaccine in children aged 5-11, meaning that age group could receive a vaccine as early as next month.
Kate Fisher reports from Washington
IN: The trial
OUT: SOC
DUR: 38 seconds
clip: http://fsnradionews.com/feeds/1025moderna-kf.mp3